BIOMAT Database Logo BIOMAT Database Logo

Technetium-99m-tetrofosmin scintigraphy, P-glycoprotein and lung cancer. 1998

M J Tabuenca, and J A Vargas, and A Varela, and C Salas, and A Durántez, and J Ortiz Berrocal

UI MeSH Term Description Entries
D008171 Lung Diseases Pathological processes involving any part of the LUNG. Pulmonary Diseases,Disease, Pulmonary,Diseases, Pulmonary,Pulmonary Disease,Disease, Lung,Diseases, Lung,Lung Disease
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D015609 Organotechnetium Compounds Organic compounds that contain technetium as an integral part of the molecule. These compounds are often used as radionuclide imaging agents. Compounds, Organotechnetium
D015899 Tomography, Emission-Computed, Single-Photon A method of computed tomography that uses radionuclides which emit a single photon of a given energy. The camera is rotated 180 or 360 degrees around the patient to capture images at multiple positions along the arc. The computer is then used to reconstruct the transaxial, sagittal, and coronal images from the 3-dimensional distribution of radionuclides in the organ. The advantages of SPECT are that it can be used to observe biochemical and physiological processes as well as size and volume of the organ. The disadvantage is that, unlike positron-emission tomography where the positron-electron annihilation results in the emission of 2 photons at 180 degrees from each other, SPECT requires physical collimation to line up the photons, which results in the loss of many available photons and hence degrades the image. CAT Scan, Single-Photon Emission,CT Scan, Single-Photon Emission,Radionuclide Tomography, Single-Photon Emission-Computed,SPECT,Single-Photon Emission-Computed Tomography,Tomography, Single-Photon, Emission-Computed,Single-Photon Emission CT Scan,Single-Photon Emission Computer-Assisted Tomography,Single-Photon Emission Computerized Tomography,CAT Scan, Single Photon Emission,CT Scan, Single Photon Emission,Emission-Computed Tomography, Single-Photon,Radionuclide Tomography, Single Photon Emission Computed,Single Photon Emission CT Scan,Single Photon Emission Computed Tomography,Single Photon Emission Computer Assisted Tomography,Single Photon Emission Computerized Tomography,Tomography, Single-Photon Emission-Computed
D017256 Technetium Tc 99m Sestamibi A technetium imaging agent used to reveal blood-starved cardiac tissue during a heart attack. 99mTc-Hexamibi,99mTc-Sestamibi,Tc MIBI,Cardiolite,Tc-99m-Methoxy-2-isobutylisonitrile,Technetium Tc 99m 2-Methoxy-2-methylpropylisonitrile,Technetium Tc 99m Sestamibi Chloride,Technetium-99m-Hexamibi,Technetium-99m-Sestamibi,99mTc Hexamibi,99mTc Sestamibi,Tc 99m Methoxy 2 isobutylisonitrile,Technetium 99m Hexamibi,Technetium 99m Sestamibi,Technetium Tc 99m 2 Methoxy 2 methylpropylisonitrile
D019275 Radiopharmaceuticals Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) Radiopharmaceutical
D020168 ATP Binding Cassette Transporter, Subfamily B, Member 1 A 170-kDa transmembrane glycoprotein from the superfamily of ATP-BINDING CASSETTE TRANSPORTERS. It serves as an ATP-dependent efflux pump for a variety of chemicals, including many ANTINEOPLASTIC AGENTS. Overexpression of this glycoprotein is associated with multidrug resistance (see DRUG RESISTANCE, MULTIPLE). ATP-Dependent Translocase ABCB1,MDR1 Protein,MDR1B Protein,Multidrug Resistance Protein 1,P-Glycoprotein,P-Glycoprotein 1,ABCB1 Protein,ATP Binding Cassette Transporter, Sub-Family B, Member 1,ATP-Binding Cassette, Sub-Family B, Member 1,CD243 Antigen,PGY-1 Protein,1, P-Glycoprotein,ABCB1, ATP-Dependent Translocase,ATP Dependent Translocase ABCB1,Antigen, CD243,P Glycoprotein,P Glycoprotein 1,PGY 1 Protein,Protein, MDR1B,Translocase ABCB1, ATP-Dependent

Related Publications

M J Tabuenca, and J A Vargas, and A Varela, and C Salas, and A Durántez, and J Ortiz Berrocal
Differences between technetium-99m tetrofosmin and technetium-99m sestamibi in parathyroid scintigraphy.
March 1997, European journal of nuclear medicine,
M J Tabuenca, and J A Vargas, and A Varela, and C Salas, and A Durántez, and J Ortiz Berrocal
Parathyroid scintigraphy: comparison of technetium-99m methoxyisobutylisonitrile and technetium-99m tetrofosmin studies.
June 1996, European journal of nuclear medicine,
M J Tabuenca, and J A Vargas, and A Varela, and C Salas, and A Durántez, and J Ortiz Berrocal
Technetium-99m-tetrofosmin scintigraphy in pulmonary tuberculosis.
December 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
M J Tabuenca, and J A Vargas, and A Varela, and C Salas, and A Durántez, and J Ortiz Berrocal
Technetium-99m tetrofosmin scintigraphy in the diagnosis of breast cancer.
August 1996, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
M J Tabuenca, and J A Vargas, and A Varela, and C Salas, and A Durántez, and J Ortiz Berrocal
Technetium-99m tetrofosmin scintigraphy in pediatric osteogenic sarcoma.
January 2003, Oncology reports,
M J Tabuenca, and J A Vargas, and A Varela, and C Salas, and A Durántez, and J Ortiz Berrocal
Technetium-99m tetrofosmin scintigraphy for detecting malignant lymphoma.
January 2001, Anticancer research,
M J Tabuenca, and J A Vargas, and A Varela, and C Salas, and A Durántez, and J Ortiz Berrocal
Technetium-99m tetrofosmin scintigraphy to evaluate breast lesions.
January 1997, Anticancer research,
M J Tabuenca, and J A Vargas, and A Varela, and C Salas, and A Durántez, and J Ortiz Berrocal
Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning.
August 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
M J Tabuenca, and J A Vargas, and A Varela, and C Salas, and A Durántez, and J Ortiz Berrocal
Assessment of thyroid nodules by technetium-99m-tetrofosmin scintigraphy.
January 1997, The British journal of clinical practice,
M J Tabuenca, and J A Vargas, and A Varela, and C Salas, and A Durántez, and J Ortiz Berrocal
Predicting multidrug resistance-related protein and P-glycoprotein expression with technetium-99m tetrofosmin mammoscintigraphy.
February 2003, Breast (Edinburgh, Scotland),
Copied contents to your clipboard!